• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Dogs With Cancer Helping People With Cancer

March 4, 2016
Laurie Anne Walden, DVM, ELS

A recent report shows that including dogs with cancer in studies of oncology drugs can speed the drug development process.

Comparative Oncology: Report from NAM Workshop

Including dogs with cancer in studies of oncology drugs can speed the drug development process, according to a recently published report from the National Academy of Medicine’s Workshop on Comparative Oncology. Tapping the potential of comparative oncology, a branch of research that studies cancer across species, can improve therapeutic options for both dogs and people.

Advertisement

“We are hopeful this analysis will be useful in developing and advancing an agenda for the field of comparative oncology,” said Dr. Jeffrey Trent, one of the study authors, in a press release. “Many canine breeds develop naturally occurring cancers, such as breast cancer and melanoma, that share remarkable genetic similarities with their human equivalent.”

Scientists at the workshop discussed gaps in comparative oncology research. Conclusions from workshop sessions include the following:

  • Researchers and the general public do not fully understand the potential benefits of comparative oncology research.
  • The biologic behavior of some cancers is nearly identical in dogs and humans.
  • Studies of the genomic characteristics of canine cancers could advance the development of gene-based therapies in both species.
  • Performing preclinical studies in pet dogs with cancer may improve the success rates of similar studies in humans.
  • Imaging modalities used to detect cancer and monitor treatment in humans are already available in veterinary referral hospitals. The same types of imaging used in humans for end-point monitoring, including computed tomography and magnetic resonance imaging, can be employed in parallel studies of both species.
  • Veterinary schools are the best resource for recruiting and managing dogs with cancer for drug development studies.
  • A clinical trial registry for pets with cancer is needed.
  • Toxicity data from studies of dogs with cancer will be treated as supplementary (not on the same level as data from controlled toxicology studies) by the Food and Drug Administration. According to the report, “This clarity alone was widely considered to be the most important outcome” of the meeting.

Dr. Laurie Anne Walden received her doctorate in veterinary medicine from North Carolina State University in 1994. After an internship at Auburn University College of Veterinary Medicine, she returned to North Carolina, where she has been in companion animal general practice for over 20 years. Dr. Walden is also a board-certified Editor in the Life Sciences and owner of Walden Medical Writing.


Advertisement

Latest News

New technology and products for veterinary genealogy

Reduce your veterinary teams’ stress with financial wellness

Cuban crocodiles receive surgery to extract foreign items

Purina Pro Plan Veterinary Diets joins forces with AVMF

View More Latest News
Advertisement